ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,298.43
0.03%
US Tech 100
18,012.40
-0.37%
다우존스 지수
39,953.64
0.21%
Bitcoin
66,857.47
2.48%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Bellerophon Therapeutics Inc (BLPH)

  7. Bellerophon Therapeutics Inc (BLPH) 뉴스

BLPH

Bellerophon Therapeutics (BLPH)

Bellerophon Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BLPH
일자시간출처헤드라인심볼기업
2024/01/3023:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
2024/01/2704:31Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLPHBellerophon Therapeutics Inc
2024/01/2700:46Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLPHBellerophon Therapeutics Inc
2024/01/2305:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
2024/01/1106:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
2024/01/0403:49Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/2723:50Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1709:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1702:59Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1702:59Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1702:58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1702:58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1702:57Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1702:56Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1702:56Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1702:55Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1702:54Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1323:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
2023/10/1321:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
2023/08/1505:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLPHBellerophon Therapeutics Inc
2023/08/0805:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
2023/07/2505:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
2023/07/2105:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
2023/07/1505:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
2023/06/3005:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLPHBellerophon Therapeutics Inc
2023/06/3005:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
2023/06/1219:45Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BLPHBellerophon Therapeutics Inc
2023/06/1005:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLPHBellerophon Therapeutics Inc
2023/06/1005:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLPHBellerophon Therapeutics Inc
2023/06/1005:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLPHBellerophon Therapeutics Inc
 검색 관련기사 보기:NASDAQ:BLPH

최근 히스토리

CCOM
US30
US 30
NYSE
AXP
American Express
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
CVX
Chevron
NASDAQ
NVDA
NVIDIA
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
SPY
SPDR S&P 500
NYSE
JPM
JP Morgan Chase
NYSE
BAC
Bank of America
CCOM
SILVER
SILVER
NYSE
NKE
Nike
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
NYSE
KO
Coca Cola
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유